Orange County Man’s Heart Function Quintuples after Stem Cell Therapy October 15, 2007
Posted by TheraVitae in : Press Releases , trackbackHeart Function Goes Up From 10% to 50%
Orange County 10/16/2007 05:05 AM GMT (TransWorldNews - Top Story)
Donald Cecil reports that his heart function has quintupled after receiving adult stem cell therapy in Thailand. Donald says his ejection fraction (a measure of the heart’s pumping ability) has increased from 10% to 50% almost one year after his stem cell procedure.
Before going to Thailand to receive Theravitae’s patented Vescell adult stem cell therapy, Don was suffering from congestive heart failure. “Two heart attacks had severely damaged my heart. I couldn’t walk 30 feet without passing out or taking a knee. I kept getting worse and worse. My doctor told me that the left side of my heart had given up on me. I had to give up surfing which is what I love.”
Don was treated in October, 2006 at Bangkok Heart Hospital where he received “care that easily surpassed the hospitals in the U.S. They were great.” Don’s own stem cells were injected back into his heart in a minimally invasive surgical procedure.
Asked about his decision to come to Bangkok for the stem cell treatment, Don commented, “It was an easy decision to make because I was dying. I wasn’t scared at all because it was something I had to do to keep me going. This was it for me.”
Almost one year later, Don has seen his quality of life improve dramatically. Don is surfing again and just returned from a surfing trip in Mexico. “It was great, I could paddle out again and surf overhead waves. I would be happy to recommend this to anybody. Just have them give me a call.”
About TheraVitae:
TheraVitae is a private, multinational company focused on using stem cells from the patient’s own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, ‘VesCell’, that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease and peripheral artery disease.
VesCell — A Natural Treatment for Heart Disease and Peripheral Arterial Disease (PAD)
The body has natural ways of healing itself and the cardiovascular system is no exception. Angiogenic Cell Precursors (ACPs) originate in bone marrow and then circulate in the blood vessels. To manufacture VesCell, TheraVitae expands a small number of ACPs harvested from about 250cc of blood into a therapeutic quantity. VesCell is injected either through a coronary artery via catheter, or during surgery, directly into the heart muscle.
A key aspect of VesCell therapy is the advanced cell isolation and expansion technique that allows for the ACPs to be harvested from blood collected in a procedure similar to a common blood donation. VesCell uses a patient’s own adult stem cells to treat Heart Disease and PAD and is a viable therapeutic possibility for heart or PAD patients without any other treatment option.
